TRV GP III, LLC
- SEC CIK
- 0001637299
- Latest filing
- Feb 14, 2024
JNCE holding history
Jounce Therapeutics, Inc. in every 13F filed by TRV GP III, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JNCE overviewAll 13F holders of JNCEFull Q4 2023 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −1,148,780−100.0% | Sold out | Holders |
| Q3 2022 | 1,148,780 | $2.69M | 1.2% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,148,780 | $3.48M | 1.4% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,148,780 | $7.80M | 2.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,148,780 | $9.59M | 2.4% | −1,900,000−62.3% | Reduced | Holders |
| Q3 2021 | 3,048,780 | $22.7M | 4.3% | 00.0% | Unchanged | Holders |
| Q2 2021 | 3,048,780 | $20.7M | 3.6% | 00.0% | Unchanged | Holders |
| Q1 2021 | 3,048,780 | $31.3M | 4.0% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.